Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 17.87%846.96M | 1.30%766.99M | 18.75%719.45M | -0.96%2.94B | 6.98%856.35M | -7.38%718.53M | -6.05%757.16M | 3.69%605.84M | -7.00%2.97B | 1.17%800.46M |
| Cost of revenue | 20.11%626.9M | -1.40%561.63M | 4.77%482.14M | -4.52%2.12B | -2.49%566.43M | -6.74%521.95M | -8.59%569.6M | 1.19%460.19M | 1.06%2.22B | -3.35%580.9M |
| Gross profit | 11.94%220.06M | 9.49%205.37M | 62.93%237.31M | 9.59%819.71M | 32.04%289.92M | -9.04%196.59M | 2.57%187.56M | 12.50%145.65M | -24.80%748M | 15.47%219.56M |
| Operating expense | 27.57%77.42M | -278.43%-106.77M | 69.39%123.61M | -6.21%275.7M | -18.94%82.21M | -18.45%60.69M | -8.82%59.84M | 39.01%72.97M | 16.46%293.95M | 1.13%101.42M |
| Selling and administrative expenses | ---- | ---- | ---- | -10.53%270.61M | ---- | ---- | ---- | ---- | 22.88%302.44M | ---- |
| -Selling and marketing expense | ---- | ---- | ---- | -33.04%74.94M | ---- | ---- | ---- | ---- | 30.08%111.91M | ---- |
| -General and administrative expense | ---- | ---- | ---- | 2.70%195.67M | ---- | ---- | ---- | ---- | 19.01%190.53M | ---- |
| Other operating expenses | 19.05%89.8M | 113.06%171.94M | 71.79%139.56M | 45.65%67.48M | -11.09%100.72M | -12.37%75.43M | 4.56%80.7M | 12.48%81.24M | -27.60%46.33M | 187.82%113.29M |
| Total other operating income | -16.02%12.38M | 1,235.76%278.71M | 92.98%15.95M | 13.80%62.38M | 55.97%18.51M | 26.40%14.74M | 80.51%20.87M | -58.12%8.26M | -5.03%54.82M | -29.55%11.87M |
| Operating profit | 4.96%142.64M | 144.38%312.13M | 56.45%113.7M | 19.81%544M | 75.81%207.71M | -4.10%135.9M | 8.95%127.72M | -5.58%72.67M | -38.83%454.04M | 31.48%118.15M |
| Net non-operating interest income (expenses) | 19.39%-28.34M | -28.02%-34.31M | -27.22%-32.65M | -15.86%-123.67M | -38.40%-36.05M | -26.79%-35.15M | -3.48%-26.8M | 5.20%-25.66M | -17.14%-106.74M | -106.12%-26.05M |
| Non-operating interest expense | -19.39%28.34M | 28.02%34.31M | 27.22%32.65M | 15.28%121.27M | 38.40%36.05M | 26.79%35.15M | 3.48%26.8M | -5.20%25.66M | 17.39%105.2M | 134.03%26.05M |
| Total other finance cost | ---- | ---- | ---- | 55.38%2.4M | ---- | ---- | ---- | ---- | 2.46%1.54M | ---- |
| Net investment income | 479.16%16.99M | -288.04%-4.48M | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 84.49%-215K | -1.39M | ||||||||
| Income from associates and other participating interests | -8.73%7.94M | -50.69%4.4M | -19.05%8.78M | 2.00%43.56M | 58.30%15.08M | -26.45%8.7M | -21.61%8.92M | 8.91%10.85M | 20.69%42.7M | 87.28%9.53M |
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | -89.56%1.89M | -722.28%-3.88M | -91.12%257K | -335.15%-4.79M | 962.76%18.05M | -61.10%624K | 167.63%2.89M | -1.1M | ||
| Income before tax | -2.64%124.13M | 151.96%278.34M | 48.28%90.09M | 25.13%480.67M | 81.00%181.95M | 3.05%127.49M | 5.90%110.47M | 9.31%60.75M | -44.24%384.14M | 49.93%100.52M |
| Income tax | -3.43%34.73M | 165.77%85.48M | 28.64%27.08M | 23.12%145.71M | 41.45%56.54M | -2.31%35.96M | 20.49%32.16M | 41.55%21.05M | -42.42%118.35M | 17.80%39.97M |
| Net income | -2.33%89.4M | 146.29%192.87M | 58.70%63.01M | 26.02%334.96M | 107.11%125.42M | 5.33%91.53M | 0.88%78.31M | -2.47%39.7M | -45.01%265.79M | 82.85%60.56M |
| Net income continuous operations | -2.33%89.4M | 146.29%192.87M | 58.70%63.01M | 26.02%334.96M | 107.11%125.42M | 5.33%91.53M | 0.88%78.31M | -2.47%39.7M | -45.01%265.79M | 82.85%60.56M |
| Noncontrolling interests | -65.83%2.9M | 104.29%292K | 155.88%1.75M | -3.27%11.9M | 606.56%13.36M | 32.89%8.48M | -202.21%-6.81M | -264.74%-3.13M | 3.29%12.3M | 88.40%-2.64M |
| Net income attributable to the company | 4.15%86.5M | 126.24%192.57M | 43.02%61.26M | 27.44%323.06M | 77.32%112.05M | 3.15%83.05M | 19.94%85.12M | 10.37%42.83M | -46.23%253.49M | 13.13%63.19M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 4.15%86.5M | 126.24%192.57M | 43.02%61.26M | 27.44%323.06M | 77.32%112.05M | 3.15%83.05M | 19.94%85.12M | 10.37%42.83M | -46.23%253.49M | 13.13%63.19M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 4.10%0.0964 | 126.13%0.2146 | 43.19%0.0683 | 27.47%0.3601 | 77.41%0.1249 | 3.23%0.0926 | 19.97%0.0949 | 10.16%0.0477 | -46.23%0.2825 | 13.18%0.0704 |
| Diluted earnings per share | 4.10%0.0964 | 126.13%0.2146 | 43.19%0.0683 | 27.47%0.3601 | 77.41%0.1249 | 3.23%0.0926 | 19.97%0.0949 | 10.16%0.0477 | -46.23%0.2825 | 13.18%0.0704 |
| Dividend per share | 25.00%0.1 | 0 | 0.00%0.04 | 0.00%0.12 | 0 | 0.00%0.08 | 0 | 0.00%0.04 | -36.84%0.12 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.